Boehringer Ingelheim · 2 weeks ago
Executive Director, Computational Safety
Boehringer Ingelheim is seeking a visionary leader to build and lead their Computational Safety team. This role involves shaping strategy and delivering impactful solutions across therapeutic portfolios while driving innovation in predictive safety assessment using modern computational approaches.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Strategic Leadership: Define and implement the computational safety strategy in alignment with broader Computational Innovation objectives in the Innovation Unit (IU). Provide long-term vision and oversee cross-functional integration with Research, Clinical Pharmacology, Safety, and IT
Impact Delivery: Lead the development of AI models and computational tools to generate data-driven insights and deliver in silico safety reports for portfolio projects. Manage project timelines and budgets for timely, cost-effective results
Innovation: Stay at the forefront of computational safety advancements across industry, collaborate with academic partners, and integrate new technologies and approaches into our drug discovery and development processes
Cross-functional Collaboration: Collaborate with other Computational Innovation teams (Computational Biology, Human Genetics, Data Excellence, AI/ML) and with partner functions to deliver computational solutions that impact projects. Build and maintain strategic relationships across the organizations
Team Management & Development: Build, mentor, and lead a high-performing team. Represent the organization externally and influence global governance
Qualification
Required
Ph.D. degree in Computational Biology/Chemistry/Toxicology, Bioinformatics, Computer Science, Data Science, or a related scientific field required
Minimum 10- 15 years of experience in computational drug safety in a pharmaceutical company, with deep knowledge of toxicology, pharmacology, and the role of safety and computation in the drug discovery and development process
Five-plus (5+) years of experience in strategic leadership, global team management, and cross-functional influence
Experience managing budgets, outsourcing, and cross-site operations
Demonstrated track record of translating computational innovation, e.g., AI/ML methods, predictive modeling, multi-omics data analysis, and effective use of public/commercial data sources into tangible decisions and impacts in drug portfolio projects
Proven ability to deliver scalable, high-impact insights and tools that shape decision-making
Respected contributor to strategic conversations, even without formal team leadership
Demonstrated track record of initiating, building, and scaling ideas across silos
Must be legally authorized to work in the United States without restriction
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Benefits
Role specific variable or performance-based bonus
Other compensation elements
Company
Boehringer Ingelheim
Boehringer Ingelheim is a group of pharmaceutical companies that focuses on prescription medicines and animal health. It is a sub-organization of Boehringer Ingelheim.
Funding
Current Stage
Late StageLeadership Team
Recent News
Company data provided by crunchbase